Among these subjects , the median decline in the FEV1 after the use of a bronchodilator over the three-year period was 140 ml in the budesonide group and 180 ml in the placebo group ( P = 0.05 ) , or 4.3 percent and 5.3 percent of the predicted value , respectively .
